nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Teniposide—hematologic cancer	0.185	1	CrCtD
Etoposide—muscle cancer—hematologic cancer	0.131	1	CtDrD
Etoposide—Podofilox—Teniposide—hematologic cancer	0.105	1	CrCrCtD
Etoposide—Topoisomerase Inhibitors—Daunorubicin—hematologic cancer	0.0557	0.219	CiPCiCtD
Etoposide—TOP2B—hematologic cancer	0.0503	0.422	CbGaD
Etoposide—Topoisomerase Inhibitors—Teniposide—hematologic cancer	0.0474	0.186	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Idarubicin—hematologic cancer	0.0423	0.166	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Irinotecan—hematologic cancer	0.0359	0.141	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Mitoxantrone—hematologic cancer	0.0359	0.141	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Epirubicin—hematologic cancer	0.0194	0.0762	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Doxorubicin—hematologic cancer	0.0179	0.0705	CiPCiCtD
Etoposide—TOP2B—Daunorubicin—hematologic cancer	0.0141	0.102	CbGbCtD
Etoposide—ABCC3—hematologic cancer	0.0139	0.116	CbGaD
Etoposide—GSTT1—hematologic cancer	0.0132	0.111	CbGaD
Etoposide—UGT1A1—hematologic cancer	0.012	0.101	CbGaD
Etoposide—GSTP1—hematologic cancer	0.0104	0.0875	CbGaD
Etoposide—TOP2A—hematologic cancer	0.00986	0.0828	CbGaD
Etoposide—GSTP1—Busulfan—hematologic cancer	0.00928	0.067	CbGbCtD
Etoposide—GSTP1—Chlorambucil—hematologic cancer	0.00827	0.0598	CbGbCtD
Etoposide—ABCG2—hematologic cancer	0.00674	0.0565	CbGaD
Etoposide—ABCC6—Daunorubicin—hematologic cancer	0.00538	0.0389	CbGbCtD
Etoposide—ABCC6—Teniposide—hematologic cancer	0.00467	0.0338	CbGbCtD
Etoposide—ABCC10—Daunorubicin—hematologic cancer	0.00411	0.0297	CbGbCtD
Etoposide—TOP2A—Idarubicin—hematologic cancer	0.00404	0.0292	CbGbCtD
Etoposide—GSTT1—Cisplatin—hematologic cancer	0.00365	0.0264	CbGbCtD
Etoposide—ABCC10—Cytarabine—hematologic cancer	0.00362	0.0262	CbGbCtD
Etoposide—TOP2A—Daunorubicin—hematologic cancer	0.00286	0.0207	CbGbCtD
Etoposide—ABCB1—hematologic cancer	0.00281	0.0235	CbGaD
Etoposide—TOP2A—Teniposide—hematologic cancer	0.00249	0.018	CbGbCtD
Etoposide—ABCC6—Vinblastine—hematologic cancer	0.00229	0.0165	CbGbCtD
Etoposide—GSTP1—Cisplatin—hematologic cancer	0.00228	0.0165	CbGbCtD
Etoposide—ABCC1—Idarubicin—hematologic cancer	0.00224	0.0162	CbGbCtD
Etoposide—ABCC10—Gemcitabine—hematologic cancer	0.00221	0.0159	CbGbCtD
Etoposide—ABCC6—Cisplatin—hematologic cancer	0.0021	0.0152	CbGbCtD
Etoposide—PTGS2—Lenalidomide—hematologic cancer	0.00198	0.0143	CbGbCtD
Etoposide—ABCG2—Clofarabine—hematologic cancer	0.00181	0.0131	CbGbCtD
Etoposide—TOP2A—Mitoxantrone—hematologic cancer	0.00174	0.0126	CbGbCtD
Etoposide—ABCC10—Vincristine—hematologic cancer	0.00172	0.0124	CbGbCtD
Etoposide—ABCC1—Daunorubicin—hematologic cancer	0.00159	0.0115	CbGbCtD
Etoposide—TOP2A—Epirubicin—hematologic cancer	0.00141	0.0102	CbGbCtD
Etoposide—ABCC6—Doxorubicin—hematologic cancer	0.00141	0.0102	CbGbCtD
Etoposide—UGT1A1—Nilotinib—hematologic cancer	0.00134	0.00971	CbGbCtD
Etoposide—ABCC2—Daunorubicin—hematologic cancer	0.00117	0.00849	CbGbCtD
Etoposide—ABCC3—Vincristine—hematologic cancer	0.00108	0.00781	CbGbCtD
Etoposide—CYP1A2—Anagrelide—hematologic cancer	0.00108	0.00778	CbGbCtD
Etoposide—ABCC10—Doxorubicin—hematologic cancer	0.00107	0.00776	CbGbCtD
Etoposide—ABCG2—Daunorubicin—hematologic cancer	0.00106	0.00767	CbGbCtD
Etoposide—PTGS2—Thalidomide—hematologic cancer	0.00106	0.00764	CbGbCtD
Etoposide—ABCC10—Methotrexate—hematologic cancer	0.00104	0.00752	CbGbCtD
Etoposide—PTGS1—Bortezomib—hematologic cancer	0.00102	0.0074	CbGbCtD
Etoposide—ABCC3—Cisplatin—hematologic cancer	0.00101	0.00728	CbGbCtD
Etoposide—ABCC1—Mitoxantrone—hematologic cancer	0.000964	0.00697	CbGbCtD
Etoposide—UGT1A1—Irinotecan—hematologic cancer	0.000923	0.00667	CbGbCtD
Etoposide—ABCG2—Teniposide—hematologic cancer	0.000922	0.00667	CbGbCtD
Etoposide—PTGS1—Thalidomide—hematologic cancer	0.000892	0.00645	CbGbCtD
Etoposide—ABCG2—Cladribine—hematologic cancer	0.000884	0.00639	CbGbCtD
Etoposide—ABCG2—Imatinib—hematologic cancer	0.000813	0.00588	CbGbCtD
Etoposide—PTGS1—Ifosfamide—hematologic cancer	0.000786	0.00568	CbGbCtD
Etoposide—ABCC1—Epirubicin—hematologic cancer	0.00078	0.00564	CbGbCtD
Etoposide—ABCC1—Irinotecan—hematologic cancer	0.000759	0.00548	CbGbCtD
Etoposide—PTGS1—Imatinib—hematologic cancer	0.000751	0.00542	CbGbCtD
Etoposide—TOP2A—Doxorubicin—hematologic cancer	0.000748	0.00541	CbGbCtD
Etoposide—ABCG2—Nilotinib—hematologic cancer	0.000739	0.00534	CbGbCtD
Etoposide—PTGS2—Triamcinolone—hematologic cancer	0.000732	0.00529	CbGbCtD
Etoposide—CYP2E1—Thalidomide—hematologic cancer	0.000689	0.00498	CbGbCtD
Etoposide—ABCC3—Doxorubicin—hematologic cancer	0.000675	0.00488	CbGbCtD
Etoposide—ABCC1—Vinblastine—hematologic cancer	0.000675	0.00488	CbGbCtD
Etoposide—ABCC1—Vincristine—hematologic cancer	0.000663	0.00479	CbGbCtD
Etoposide—ABCC3—Methotrexate—hematologic cancer	0.000654	0.00473	CbGbCtD
Etoposide—ABCG2—Dasatinib—hematologic cancer	0.000653	0.00472	CbGbCtD
Etoposide—ABCB1—Lenalidomide—hematologic cancer	0.000653	0.00472	CbGbCtD
Etoposide—ABCG2—Mitoxantrone—hematologic cancer	0.000645	0.00466	CbGbCtD
Etoposide—PTGS2—ovarian follicle—hematologic cancer	0.000645	0.0734	CbGeAlD
Etoposide—PTGS2—Betamethasone—hematologic cancer	0.000628	0.00454	CbGbCtD
Etoposide—CYP2E1—Dacarbazine—hematologic cancer	0.000593	0.00428	CbGbCtD
Etoposide—CYP2C8—Bortezomib—hematologic cancer	0.000591	0.00427	CbGbCtD
Etoposide—CYP3A5—Daunorubicin—hematologic cancer	0.000588	0.00425	CbGbCtD
Etoposide—CYP1A2—Carmustine—hematologic cancer	0.000566	0.00409	CbGbCtD
Etoposide—ABCC2—Irinotecan—hematologic cancer	0.000562	0.00406	CbGbCtD
Etoposide—CYP3A5—Thalidomide—hematologic cancer	0.000536	0.00387	CbGbCtD
Etoposide—CYP3A5—Teniposide—hematologic cancer	0.000511	0.00369	CbGbCtD
Etoposide—ABCG2—Irinotecan—hematologic cancer	0.000508	0.00367	CbGbCtD
Etoposide—ABCC2—Vinblastine—hematologic cancer	0.000499	0.00361	CbGbCtD
Etoposide—ABCC2—Vincristine—hematologic cancer	0.000491	0.00355	CbGbCtD
Etoposide—CYP1A2—Methoxsalen—hematologic cancer	0.000481	0.00348	CbGbCtD
Etoposide—CYP3A5—Ifosfamide—hematologic cancer	0.000472	0.00341	CbGbCtD
Etoposide—CYP2E1—Mitoxantrone—hematologic cancer	0.00046	0.00332	CbGbCtD
Etoposide—ABCC2—Cisplatin—hematologic cancer	0.000458	0.00331	CbGbCtD
Etoposide—CYP1A2—Bortezomib—hematologic cancer	0.000458	0.00331	CbGbCtD
Etoposide—CYP2C8—Ifosfamide—hematologic cancer	0.000453	0.00328	CbGbCtD
Etoposide—PTGS2—Cisplatin—hematologic cancer	0.000453	0.00327	CbGbCtD
Etoposide—CYP3A5—Imatinib—hematologic cancer	0.00045	0.00326	CbGbCtD
Etoposide—ABCG2—Vincristine—hematologic cancer	0.000444	0.00321	CbGbCtD
Etoposide—CYP1A2—Daunorubicin—hematologic cancer	0.000438	0.00316	CbGbCtD
Etoposide—CYP1A2—Alitretinoin—hematologic cancer	0.000429	0.0031	CbGbCtD
Etoposide—Teniposide—NCOA3—hematologic cancer	0.000418	0.492	CrCbGaD
Etoposide—ABCC1—Doxorubicin—hematologic cancer	0.000415	0.003	CbGbCtD
Etoposide—ABCG2—Cisplatin—hematologic cancer	0.000414	0.00299	CbGbCtD
Etoposide—ABCC1—Methotrexate—hematologic cancer	0.000402	0.0029	CbGbCtD
Etoposide—CYP1A2—Thalidomide—hematologic cancer	0.000399	0.00288	CbGbCtD
Etoposide—CYP2C8—Nilotinib—hematologic cancer	0.000394	0.00284	CbGbCtD
Etoposide—CYP3A4—Bexarotene—hematologic cancer	0.000391	0.00283	CbGbCtD
Etoposide—ABCB1—Daunorubicin—hematologic cancer	0.000383	0.00277	CbGbCtD
Etoposide—ABCB1—Alitretinoin—hematologic cancer	0.000375	0.00271	CbGbCtD
Etoposide—ABCC2—Dexamethasone—hematologic cancer	0.00037	0.00267	CbGbCtD
Etoposide—PTGS2—Dexamethasone—hematologic cancer	0.000366	0.00264	CbGbCtD
Etoposide—CYP3A4—Busulfan—hematologic cancer	0.000364	0.00263	CbGbCtD
Etoposide—CYP3A4—Lomustine—hematologic cancer	0.000364	0.00263	CbGbCtD
Etoposide—CYP3A5—Dasatinib—hematologic cancer	0.000362	0.00261	CbGbCtD
Etoposide—GSTT1—hematopoietic system—hematologic cancer	0.000362	0.0412	CbGeAlD
Etoposide—CYP1A2—Dacarbazine—hematologic cancer	0.000343	0.00248	CbGbCtD
Etoposide—CYP1A2—Imatinib—hematologic cancer	0.000335	0.00242	CbGbCtD
Etoposide—ABCG2—Dexamethasone—hematologic cancer	0.000334	0.00242	CbGbCtD
Etoposide—CYP3A4—Thiotepa—hematologic cancer	0.000324	0.00234	CbGbCtD
Etoposide—ABCC2—Doxorubicin—hematologic cancer	0.000307	0.00222	CbGbCtD
Etoposide—ABCC2—Methotrexate—hematologic cancer	0.000297	0.00215	CbGbCtD
Etoposide—ABCC6—hematopoietic system—hematologic cancer	0.000294	0.0334	CbGeAlD
Etoposide—ABCB1—Imatinib—hematologic cancer	0.000293	0.00212	CbGbCtD
Etoposide—CYP3A5—Irinotecan—hematologic cancer	0.000281	0.00203	CbGbCtD
Etoposide—ABCG2—Doxorubicin—hematologic cancer	0.000277	0.00201	CbGbCtD
Etoposide—CYP1A2—Dasatinib—hematologic cancer	0.000269	0.00195	CbGbCtD
Etoposide—ABCG2—Methotrexate—hematologic cancer	0.000269	0.00194	CbGbCtD
Etoposide—ABCB1—Nilotinib—hematologic cancer	0.000266	0.00193	CbGbCtD
Etoposide—TOP2B—hematopoietic system—hematologic cancer	0.000266	0.0303	CbGeAlD
Etoposide—ABCB1—Vinorelbine—hematologic cancer	0.000264	0.00191	CbGbCtD
Etoposide—CYP3A4—Methoxsalen—hematologic cancer	0.000252	0.00182	CbGbCtD
Etoposide—CYP3A5—Vincristine—hematologic cancer	0.000246	0.00178	CbGbCtD
Etoposide—CYP3A4—Bortezomib—hematologic cancer	0.00024	0.00173	CbGbCtD
Etoposide—GSTT1—blood—hematologic cancer	0.00024	0.0273	CbGeAlD
Etoposide—CYP2E1—Dexamethasone—hematologic cancer	0.000238	0.00172	CbGbCtD
Etoposide—ABCB1—Dasatinib—hematologic cancer	0.000235	0.0017	CbGbCtD
Etoposide—ABCB1—Mitoxantrone—hematologic cancer	0.000233	0.00168	CbGbCtD
Etoposide—CYP3A4—Daunorubicin—hematologic cancer	0.000229	0.00166	CbGbCtD
Etoposide—UGT1A1—hematopoietic system—hematologic cancer	0.000212	0.0242	CbGeAlD
Etoposide—GSTT1—lung—hematologic cancer	0.00021	0.0239	CbGeAlD
Etoposide—ABCB1—Betamethasone—hematologic cancer	0.000207	0.0015	CbGbCtD
Etoposide—ABCB1—Gemcitabine—hematologic cancer	0.000205	0.00148	CbGbCtD
Etoposide—ABCB1—Prednisolone—hematologic cancer	0.000205	0.00148	CbGbCtD
Etoposide—TOP2B—gonad—hematologic cancer	0.000202	0.0231	CbGeAlD
Etoposide—CYP3A4—Cytarabine—hematologic cancer	0.000202	0.00146	CbGbCtD
Etoposide—CYP3A4—Teniposide—hematologic cancer	0.000199	0.00144	CbGbCtD
Etoposide—ABCC6—blood—hematologic cancer	0.000194	0.0221	CbGeAlD
Etoposide—ABCB1—Prednisone—hematologic cancer	0.000193	0.0014	CbGbCtD
Etoposide—CYP3A5—Dexamethasone—hematologic cancer	0.000185	0.00134	CbGbCtD
Etoposide—CYP3A4—Ifosfamide—hematologic cancer	0.000184	0.00133	CbGbCtD
Etoposide—ABCB1—Irinotecan—hematologic cancer	0.000183	0.00132	CbGbCtD
Etoposide—CYP2C8—Dexamethasone—hematologic cancer	0.000178	0.00129	CbGbCtD
Etoposide—TOP2B—blood—hematologic cancer	0.000176	0.0201	CbGeAlD
Etoposide—CYP3A4—Imatinib—hematologic cancer	0.000176	0.00127	CbGbCtD
Etoposide—TOP2B—bone marrow—hematologic cancer	0.000171	0.0194	CbGeAlD
Etoposide—ABCC6—lung—hematologic cancer	0.00017	0.0194	CbGeAlD
Etoposide—ABCC3—hematopoietic system—hematologic cancer	0.000168	0.0191	CbGeAlD
Etoposide—GSTP1—hematopoietic system—hematologic cancer	0.000167	0.019	CbGeAlD
Etoposide—ABCC10—hematopoietic system—hematologic cancer	0.000167	0.019	CbGeAlD
Etoposide—CYP3A4—Ruxolitinib—hematologic cancer	0.000165	0.0012	CbGbCtD
Etoposide—ABCB1—Vinblastine—hematologic cancer	0.000163	0.00118	CbGbCtD
Etoposide—ABCB1—Vincristine—hematologic cancer	0.00016	0.00116	CbGbCtD
Etoposide—CYP3A4—Nilotinib—hematologic cancer	0.00016	0.00115	CbGbCtD
Etoposide—CYP3A4—Vinorelbine—hematologic cancer	0.000158	0.00114	CbGbCtD
Etoposide—TOP2B—lung—hematologic cancer	0.000155	0.0176	CbGeAlD
Etoposide—ABCB1—Cisplatin—hematologic cancer	0.000149	0.00108	CbGbCtD
Etoposide—TOP2B—testis—hematologic cancer	0.000146	0.0166	CbGeAlD
Etoposide—CYP3A4—Triamcinolone—hematologic cancer	0.000145	0.00105	CbGbCtD
Etoposide—Podofilox—TOP2A—hematologic cancer	0.000143	0.168	CrCbGaD
Etoposide—CYP3A4—Dasatinib—hematologic cancer	0.000141	0.00102	CbGbCtD
Etoposide—UGT1A1—blood—hematologic cancer	0.000141	0.016	CbGeAlD
Etoposide—CYP3A4—Mitoxantrone—hematologic cancer	0.000139	0.00101	CbGbCtD
Etoposide—TOP2A—blood—hematologic cancer	0.00013	0.0148	CbGeAlD
Etoposide—GSTP1—gonad—hematologic cancer	0.000127	0.0144	CbGeAlD
Etoposide—ABCC10—gonad—hematologic cancer	0.000127	0.0144	CbGeAlD
Etoposide—TOP2A—bone marrow—hematologic cancer	0.000126	0.0143	CbGeAlD
Etoposide—CYP3A4—Betamethasone—hematologic cancer	0.000124	0.000898	CbGbCtD
Etoposide—CYP3A4—Prednisolone—hematologic cancer	0.000123	0.000886	CbGbCtD
Etoposide—Teniposide—TOP2A—hematologic cancer	0.000121	0.143	CrCbGaD
Etoposide—ABCB1—Dexamethasone—hematologic cancer	0.000121	0.000872	CbGbCtD
Etoposide—CYP3A4—Prednisone—hematologic cancer	0.000116	0.000836	CbGbCtD
Etoposide—TOP2A—lung—hematologic cancer	0.000114	0.013	CbGeAlD
Etoposide—ABCC3—blood—hematologic cancer	0.000111	0.0126	CbGeAlD
Etoposide—GSTP1—blood—hematologic cancer	0.000111	0.0126	CbGeAlD
Etoposide—ABCC10—blood—hematologic cancer	0.00011	0.0126	CbGeAlD
Etoposide—CYP3A4—Irinotecan—hematologic cancer	0.00011	0.000793	CbGbCtD
Etoposide—TOP2A—testis—hematologic cancer	0.000107	0.0122	CbGeAlD
Etoposide—GSTP1—bone marrow—hematologic cancer	0.000107	0.0122	CbGeAlD
Etoposide—ABCC10—bone marrow—hematologic cancer	0.000107	0.0122	CbGeAlD
Etoposide—TOP2B—lymph node—hematologic cancer	0.000106	0.012	CbGeAlD
Etoposide—TOP2B—Topotecan—Irinotecan—hematologic cancer	0.000105	0.166	CbGdCrCtD
Etoposide—CYP2C8—hematopoietic system—hematologic cancer	0.0001	0.0114	CbGeAlD
Etoposide—ABCB1—Doxorubicin—hematologic cancer	0.0001	0.000723	CbGbCtD
Etoposide—CYP3A4—Vinblastine—hematologic cancer	9.75e-05	0.000705	CbGbCtD
Etoposide—ABCC3—lung—hematologic cancer	9.73e-05	0.0111	CbGeAlD
Etoposide—ABCB1—Methotrexate—hematologic cancer	9.69e-05	0.0007	CbGbCtD
Etoposide—GSTP1—lung—hematologic cancer	9.69e-05	0.011	CbGeAlD
Etoposide—ABCC10—lung—hematologic cancer	9.68e-05	0.011	CbGeAlD
Etoposide—CYP3A4—Vincristine—hematologic cancer	9.59e-05	0.000693	CbGbCtD
Etoposide—CYP1A2—hematopoietic system—hematologic cancer	9.4e-05	0.0107	CbGeAlD
Etoposide—ABCC3—testis—hematologic cancer	9.18e-05	0.0105	CbGeAlD
Etoposide—GSTP1—testis—hematologic cancer	9.14e-05	0.0104	CbGeAlD
Etoposide—ABCC10—testis—hematologic cancer	9.14e-05	0.0104	CbGeAlD
Etoposide—CYP3A5—hematopoietic system—hematologic cancer	9.06e-05	0.0103	CbGeAlD
Etoposide—ABCC2—blood—hematologic cancer	8.87e-05	0.0101	CbGeAlD
Etoposide—CYP2E1—hematopoietic system—hematologic cancer	8.45e-05	0.00963	CbGeAlD
Etoposide—Podofilox—NR3C1—hematologic cancer	8.42e-05	0.0991	CrCbGaD
Etoposide—Teniposide—ABCG2—hematologic cancer	8.3e-05	0.0977	CrCbGaD
Etoposide—PTGS1—hematopoietic system—hematologic cancer	8.14e-05	0.00927	CbGeAlD
Etoposide—ABCC1—blood—hematologic cancer	7.81e-05	0.0089	CbGeAlD
Etoposide—PTGS2—hematopoietic system—hematologic cancer	7.78e-05	0.00886	CbGeAlD
Etoposide—TOP2A—lymph node—hematologic cancer	7.78e-05	0.00886	CbGeAlD
Etoposide—ABCC2—testis—hematologic cancer	7.34e-05	0.00836	CbGeAlD
Etoposide—CYP3A4—Dexamethasone—hematologic cancer	7.23e-05	0.000522	CbGbCtD
Etoposide—ABCC6—Podofilox—Teniposide—hematologic cancer	7.12e-05	0.112	CbGdCrCtD
Etoposide—ABCC1—lung—hematologic cancer	6.85e-05	0.0078	CbGeAlD
Etoposide—CYP3A4—hematopoietic system—hematologic cancer	6.8e-05	0.00775	CbGeAlD
Etoposide—ABCC3—lymph node—hematologic cancer	6.65e-05	0.00758	CbGeAlD
Etoposide—CYP2C8—blood—hematologic cancer	6.65e-05	0.00758	CbGeAlD
Etoposide—GSTP1—lymph node—hematologic cancer	6.63e-05	0.00755	CbGeAlD
Etoposide—ABCC10—lymph node—hematologic cancer	6.62e-05	0.00754	CbGeAlD
Etoposide—ABCG2—blood—hematologic cancer	6.47e-05	0.00737	CbGeAlD
Etoposide—ABCC1—testis—hematologic cancer	6.46e-05	0.00736	CbGeAlD
Etoposide—ABCG2—bone marrow—hematologic cancer	6.26e-05	0.00713	CbGeAlD
Etoposide—CYP1A2—blood—hematologic cancer	6.22e-05	0.00709	CbGeAlD
Etoposide—TOP2B—Menadione—Thalidomide—hematologic cancer	6.06e-05	0.0951	CbGdCrCtD
Etoposide—CYP3A5—blood—hematologic cancer	6e-05	0.00684	CbGeAlD
Etoposide—CYP3A4—Doxorubicin—hematologic cancer	5.99e-05	0.000433	CbGbCtD
Etoposide—ABCG2—lung—hematologic cancer	5.67e-05	0.00646	CbGeAlD
Etoposide—CYP2E1—blood—hematologic cancer	5.6e-05	0.00638	CbGeAlD
Etoposide—CYP2C8—testis—hematologic cancer	5.5e-05	0.00627	CbGeAlD
Etoposide—CYP1A2—lung—hematologic cancer	5.46e-05	0.00622	CbGeAlD
Etoposide—PTGS1—blood—hematologic cancer	5.39e-05	0.00614	CbGeAlD
Etoposide—ABCG2—testis—hematologic cancer	5.35e-05	0.00609	CbGeAlD
Etoposide—ABCC2—lymph node—hematologic cancer	5.32e-05	0.00606	CbGeAlD
Etoposide—CYP3A5—lung—hematologic cancer	5.26e-05	0.00599	CbGeAlD
Etoposide—PTGS2—blood—hematologic cancer	5.16e-05	0.00587	CbGeAlD
Etoposide—PTGS2—bone marrow—hematologic cancer	4.99e-05	0.00568	CbGeAlD
Etoposide—CYP2E1—lung—hematologic cancer	4.91e-05	0.00559	CbGeAlD
Etoposide—ABCB1—hematopoietic system—hematologic cancer	4.81e-05	0.00548	CbGeAlD
Etoposide—PTGS1—lung—hematologic cancer	4.73e-05	0.00539	CbGeAlD
Etoposide—ABCC1—lymph node—hematologic cancer	4.68e-05	0.00534	CbGeAlD
Etoposide—CYP2E1—testis—hematologic cancer	4.63e-05	0.00528	CbGeAlD
Etoposide—PTGS2—lung—hematologic cancer	4.52e-05	0.00515	CbGeAlD
Etoposide—CYP3A4—blood—hematologic cancer	4.51e-05	0.00513	CbGeAlD
Etoposide—PTGS1—testis—hematologic cancer	4.46e-05	0.00508	CbGeAlD
Etoposide—ABCG2—lymph node—hematologic cancer	3.88e-05	0.00442	CbGeAlD
Etoposide—ABCB1—gonad—hematologic cancer	3.66e-05	0.00417	CbGeAlD
Etoposide—PTGS1—lymph node—hematologic cancer	3.23e-05	0.00368	CbGeAlD
Etoposide—ABCB1—blood—hematologic cancer	3.19e-05	0.00363	CbGeAlD
Etoposide—PTGS2—lymph node—hematologic cancer	3.09e-05	0.00352	CbGeAlD
Etoposide—ABCB1—bone marrow—hematologic cancer	3.09e-05	0.00351	CbGeAlD
Etoposide—TOP2A—Nilotinib—Imatinib—hematologic cancer	3.07e-05	0.0482	CbGdCrCtD
Etoposide—ABCB1—lung—hematologic cancer	2.8e-05	0.00318	CbGeAlD
Etoposide—ABCB1—testis—hematologic cancer	2.64e-05	0.003	CbGeAlD
Etoposide—ABCB1—lymph node—hematologic cancer	1.91e-05	0.00218	CbGeAlD
Etoposide—TOP2A—Topotecan—Irinotecan—hematologic cancer	1.7e-05	0.0268	CbGdCrCtD
Etoposide—TOP2A—Vindesine—Vinorelbine—hematologic cancer	1.52e-05	0.0239	CbGdCrCtD
Etoposide—TOP2A—Podofilox—Teniposide—hematologic cancer	1.29e-05	0.0203	CbGdCrCtD
Etoposide—TOP2A—Vindesine—Vinblastine—hematologic cancer	1.22e-05	0.0191	CbGdCrCtD
Etoposide—TOP2A—Vindesine—Vincristine—hematologic cancer	1.22e-05	0.0191	CbGdCrCtD
Etoposide—TOP2A—Floxuridine—Pentostatin—hematologic cancer	1.17e-05	0.0184	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	1.15e-05	0.0181	CbGdCrCtD
Etoposide—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	1.15e-05	0.0181	CbGdCrCtD
Etoposide—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	1.15e-05	0.0181	CbGdCrCtD
Etoposide—TOP2A—Menadione—Thalidomide—hematologic cancer	9.79e-06	0.0154	CbGdCrCtD
Etoposide—TOP2A—Cladribine—Pentostatin—hematologic cancer	8.89e-06	0.014	CbGdCrCtD
Etoposide—TOP2A—Doxorubicin—Idarubicin—hematologic cancer	8.72e-06	0.0137	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	8.72e-06	0.0137	CbGdCrCtD
Etoposide—TOP2A—Epirubicin—Idarubicin—hematologic cancer	8.72e-06	0.0137	CbGdCrCtD
Etoposide—TOP2A—Vincristine—Vinorelbine—hematologic cancer	8.22e-06	0.0129	CbGdCrCtD
Etoposide—TOP2A—Cladribine—Clofarabine—hematologic cancer	7.92e-06	0.0124	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	7.71e-06	0.0121	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	7.71e-06	0.0121	CbGdCrCtD
Etoposide—TOP2A—Vinorelbine—Vincristine—hematologic cancer	7.69e-06	0.0121	CbGdCrCtD
Etoposide—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	7.69e-06	0.0121	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	7.54e-06	0.0118	CbGdCrCtD
Etoposide—TOP2A—Cladribine—Nelarabine—hematologic cancer	7.45e-06	0.0117	CbGdCrCtD
Etoposide—TOP2A—Floxuridine—Cladribine—hematologic cancer	7.07e-06	0.0111	CbGdCrCtD
Etoposide—TOP2A—Clofarabine—Nelarabine—hematologic cancer	6.89e-06	0.0108	CbGdCrCtD
Etoposide—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	6.61e-06	0.0104	CbGdCrCtD
Etoposide—TOP2A—Vincristine—Vinblastine—hematologic cancer	6.57e-06	0.0103	CbGdCrCtD
Etoposide—TOP2A—Cytarabine—Clofarabine—hematologic cancer	6.23e-06	0.00979	CbGdCrCtD
Etoposide—TOP2A—Cytarabine—Nelarabine—hematologic cancer	5.86e-06	0.0092	CbGdCrCtD
Etoposide—TOP2A—Cladribine—Fludarabine—hematologic cancer	5.81e-06	0.00913	CbGdCrCtD
Etoposide—TOP2A—Clofarabine—Fludarabine—hematologic cancer	5.38e-06	0.00844	CbGdCrCtD
Etoposide—TOP2A—Vinblastine—Vincristine—hematologic cancer	5.28e-06	0.0083	CbGdCrCtD
Etoposide—TOP2A—Clofarabine—Cytarabine—hematologic cancer	5.08e-06	0.00797	CbGdCrCtD
Etoposide—TOP2A—Azacitidine—Pentostatin—hematologic cancer	5.01e-06	0.00787	CbGdCrCtD
Etoposide—TOP2A—Clofarabine—Cladribine—hematologic cancer	4.95e-06	0.00777	CbGdCrCtD
Etoposide—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	4.7e-06	0.00738	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	4.66e-06	0.00731	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	4.66e-06	0.00731	CbGdCrCtD
Etoposide—TOP2A—Cytarabine—Fludarabine—hematologic cancer	4.57e-06	0.00718	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	4.55e-06	0.00714	CbGdCrCtD
Etoposide—TOP2A—Azacitidine—Clofarabine—hematologic cancer	4.47e-06	0.00702	CbGdCrCtD
Etoposide—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	4.32e-06	0.00678	CbGdCrCtD
Etoposide—TOP2A—Azacitidine—Nelarabine—hematologic cancer	4.2e-06	0.0066	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Epirubicin—hematologic cancer	4.01e-06	0.00629	CbGdCrCtD
Etoposide—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	4.01e-06	0.00629	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	4.01e-06	0.00629	CbGdCrCtD
Etoposide—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	3.71e-06	0.00582	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Doxorubicin—hematologic cancer	3.71e-06	0.00582	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	3.71e-06	0.00582	CbGdCrCtD
Etoposide—TOP2A—Azacitidine—Fludarabine—hematologic cancer	3.28e-06	0.00515	CbGdCrCtD
Etoposide—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	3.1e-06	0.00486	CbGdCrCtD
Etoposide—TOP2A—Azacitidine—Cytarabine—hematologic cancer	3.1e-06	0.00486	CbGdCrCtD
Etoposide—TOP2A—Azacitidine—Cladribine—hematologic cancer	3.02e-06	0.00474	CbGdCrCtD
Etoposide—Vomiting—Gemcitabine—hematologic cancer	2.98e-06	7.28e-05	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	2.97e-06	7.26e-05	CcSEcCtD
Etoposide—Paraesthesia—Betamethasone—hematologic cancer	2.96e-06	7.22e-05	CcSEcCtD
Etoposide—Paraesthesia—Dexamethasone—hematologic cancer	2.96e-06	7.22e-05	CcSEcCtD
Etoposide—Discomfort—Prednisone—hematologic cancer	2.96e-06	7.22e-05	CcSEcCtD
Etoposide—Rash—Gemcitabine—hematologic cancer	2.96e-06	7.22e-05	CcSEcCtD
Etoposide—Dermatitis—Gemcitabine—hematologic cancer	2.95e-06	7.21e-05	CcSEcCtD
Etoposide—Eye disorder—Epirubicin—hematologic cancer	2.95e-06	7.21e-05	CcSEcCtD
Etoposide—Headache—Gemcitabine—hematologic cancer	2.94e-06	7.17e-05	CcSEcCtD
Etoposide—Nausea—Vincristine—hematologic cancer	2.94e-06	7.17e-05	CcSEcCtD
Etoposide—Cardiac disorder—Epirubicin—hematologic cancer	2.93e-06	7.16e-05	CcSEcCtD
Etoposide—Flushing—Epirubicin—hematologic cancer	2.93e-06	7.16e-05	CcSEcCtD
Etoposide—Hypersensitivity—Prednisolone—hematologic cancer	2.91e-06	7.1e-05	CcSEcCtD
Etoposide—Hypoaesthesia—Doxorubicin—hematologic cancer	2.91e-06	7.1e-05	CcSEcCtD
Etoposide—Urinary tract disorder—Doxorubicin—hematologic cancer	2.89e-06	7.05e-05	CcSEcCtD
Etoposide—Urticaria—Triamcinolone—hematologic cancer	2.88e-06	7.04e-05	CcSEcCtD
Etoposide—Dysgeusia—Methotrexate—hematologic cancer	2.88e-06	7.03e-05	CcSEcCtD
Etoposide—Body temperature increased—Triamcinolone—hematologic cancer	2.87e-06	7.01e-05	CcSEcCtD
Etoposide—Anaphylactic shock—Prednisone—hematologic cancer	2.87e-06	7.01e-05	CcSEcCtD
Etoposide—Angiopathy—Epirubicin—hematologic cancer	2.87e-06	7e-05	CcSEcCtD
Etoposide—Urethral disorder—Doxorubicin—hematologic cancer	2.87e-06	6.99e-05	CcSEcCtD
Etoposide—Decreased appetite—Dexamethasone—hematologic cancer	2.86e-06	6.99e-05	CcSEcCtD
Etoposide—Decreased appetite—Betamethasone—hematologic cancer	2.86e-06	6.99e-05	CcSEcCtD
Etoposide—Nausea—Irinotecan—hematologic cancer	2.86e-06	6.98e-05	CcSEcCtD
Etoposide—Nausea—Mitoxantrone—hematologic cancer	2.86e-06	6.98e-05	CcSEcCtD
Etoposide—Immune system disorder—Epirubicin—hematologic cancer	2.85e-06	6.97e-05	CcSEcCtD
Etoposide—Infection—Prednisone—hematologic cancer	2.85e-06	6.96e-05	CcSEcCtD
Etoposide—Mediastinal disorder—Epirubicin—hematologic cancer	2.85e-06	6.95e-05	CcSEcCtD
Etoposide—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.84e-06	6.94e-05	CcSEcCtD
Etoposide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.84e-06	6.94e-05	CcSEcCtD
Etoposide—Back pain—Methotrexate—hematologic cancer	2.84e-06	6.94e-05	CcSEcCtD
Etoposide—Fatigue—Dexamethasone—hematologic cancer	2.84e-06	6.94e-05	CcSEcCtD
Etoposide—Fatigue—Betamethasone—hematologic cancer	2.84e-06	6.94e-05	CcSEcCtD
Etoposide—Chills—Epirubicin—hematologic cancer	2.83e-06	6.92e-05	CcSEcCtD
Etoposide—Pain—Betamethasone—hematologic cancer	2.82e-06	6.88e-05	CcSEcCtD
Etoposide—Pain—Dexamethasone—hematologic cancer	2.82e-06	6.88e-05	CcSEcCtD
Etoposide—Tachycardia—Prednisone—hematologic cancer	2.8e-06	6.84e-05	CcSEcCtD
Etoposide—Alopecia—Epirubicin—hematologic cancer	2.79e-06	6.81e-05	CcSEcCtD
Etoposide—Skin disorder—Prednisone—hematologic cancer	2.79e-06	6.8e-05	CcSEcCtD
Etoposide—Nausea—Gemcitabine—hematologic cancer	2.78e-06	6.8e-05	CcSEcCtD
Etoposide—Vomiting—Cisplatin—hematologic cancer	2.78e-06	6.78e-05	CcSEcCtD
Etoposide—Hyperhidrosis—Prednisone—hematologic cancer	2.77e-06	6.77e-05	CcSEcCtD
Etoposide—Erythema multiforme—Doxorubicin—hematologic cancer	2.76e-06	6.75e-05	CcSEcCtD
Etoposide—Rash—Cisplatin—hematologic cancer	2.76e-06	6.73e-05	CcSEcCtD
Etoposide—Dermatitis—Cisplatin—hematologic cancer	2.75e-06	6.72e-05	CcSEcCtD
Etoposide—Anorexia—Prednisone—hematologic cancer	2.74e-06	6.68e-05	CcSEcCtD
Etoposide—Eye disorder—Doxorubicin—hematologic cancer	2.73e-06	6.67e-05	CcSEcCtD
Etoposide—Ill-defined disorder—Methotrexate—hematologic cancer	2.73e-06	6.66e-05	CcSEcCtD
Etoposide—Anaemia—Methotrexate—hematologic cancer	2.72e-06	6.63e-05	CcSEcCtD
Etoposide—Feeling abnormal—Dexamethasone—hematologic cancer	2.72e-06	6.63e-05	CcSEcCtD
Etoposide—Feeling abnormal—Betamethasone—hematologic cancer	2.72e-06	6.63e-05	CcSEcCtD
Etoposide—Cardiac disorder—Doxorubicin—hematologic cancer	2.71e-06	6.62e-05	CcSEcCtD
Etoposide—Flushing—Doxorubicin—hematologic cancer	2.71e-06	6.62e-05	CcSEcCtD
Etoposide—Gastrointestinal pain—Betamethasone—hematologic cancer	2.69e-06	6.58e-05	CcSEcCtD
Etoposide—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.69e-06	6.58e-05	CcSEcCtD
Etoposide—Dysgeusia—Epirubicin—hematologic cancer	2.69e-06	6.57e-05	CcSEcCtD
Etoposide—Hypersensitivity—Triamcinolone—hematologic cancer	2.68e-06	6.53e-05	CcSEcCtD
Etoposide—Back pain—Epirubicin—hematologic cancer	2.66e-06	6.49e-05	CcSEcCtD
Etoposide—Angiopathy—Doxorubicin—hematologic cancer	2.65e-06	6.47e-05	CcSEcCtD
Etoposide—Malaise—Methotrexate—hematologic cancer	2.65e-06	6.47e-05	CcSEcCtD
Etoposide—Muscle spasms—Epirubicin—hematologic cancer	2.64e-06	6.45e-05	CcSEcCtD
Etoposide—Immune system disorder—Doxorubicin—hematologic cancer	2.64e-06	6.45e-05	CcSEcCtD
Etoposide—Vertigo—Methotrexate—hematologic cancer	2.64e-06	6.45e-05	CcSEcCtD
Etoposide—Mediastinal disorder—Doxorubicin—hematologic cancer	2.63e-06	6.43e-05	CcSEcCtD
Etoposide—Leukopenia—Methotrexate—hematologic cancer	2.63e-06	6.42e-05	CcSEcCtD
Etoposide—Chills—Doxorubicin—hematologic cancer	2.62e-06	6.4e-05	CcSEcCtD
Etoposide—Urticaria—Betamethasone—hematologic cancer	2.62e-06	6.39e-05	CcSEcCtD
Etoposide—Urticaria—Dexamethasone—hematologic cancer	2.62e-06	6.39e-05	CcSEcCtD
Etoposide—Dizziness—Prednisolone—hematologic cancer	2.61e-06	6.38e-05	CcSEcCtD
Etoposide—Asthenia—Triamcinolone—hematologic cancer	2.61e-06	6.36e-05	CcSEcCtD
Etoposide—Abdominal pain—Dexamethasone—hematologic cancer	2.6e-06	6.36e-05	CcSEcCtD
Etoposide—Abdominal pain—Betamethasone—hematologic cancer	2.6e-06	6.36e-05	CcSEcCtD
Etoposide—Body temperature increased—Dexamethasone—hematologic cancer	2.6e-06	6.36e-05	CcSEcCtD
Etoposide—Body temperature increased—Betamethasone—hematologic cancer	2.6e-06	6.36e-05	CcSEcCtD
Etoposide—Nausea—Cisplatin—hematologic cancer	2.6e-06	6.34e-05	CcSEcCtD
Etoposide—Alopecia—Doxorubicin—hematologic cancer	2.58e-06	6.31e-05	CcSEcCtD
Etoposide—Paraesthesia—Prednisone—hematologic cancer	2.58e-06	6.29e-05	CcSEcCtD
Etoposide—Pruritus—Triamcinolone—hematologic cancer	2.57e-06	6.27e-05	CcSEcCtD
Etoposide—Cough—Methotrexate—hematologic cancer	2.56e-06	6.26e-05	CcSEcCtD
Etoposide—Ill-defined disorder—Epirubicin—hematologic cancer	2.55e-06	6.23e-05	CcSEcCtD
Etoposide—Convulsion—Methotrexate—hematologic cancer	2.55e-06	6.22e-05	CcSEcCtD
Etoposide—Anaemia—Epirubicin—hematologic cancer	2.54e-06	6.21e-05	CcSEcCtD
Etoposide—Chest pain—Methotrexate—hematologic cancer	2.5e-06	6.11e-05	CcSEcCtD
Etoposide—Decreased appetite—Prednisone—hematologic cancer	2.49e-06	6.09e-05	CcSEcCtD
Etoposide—Dysgeusia—Doxorubicin—hematologic cancer	2.49e-06	6.08e-05	CcSEcCtD
Etoposide—Rash—Prednisolone—hematologic cancer	2.49e-06	6.08e-05	CcSEcCtD
Etoposide—Dermatitis—Prednisolone—hematologic cancer	2.49e-06	6.07e-05	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.48e-06	6.07e-05	CcSEcCtD
Etoposide—Malaise—Epirubicin—hematologic cancer	2.48e-06	6.05e-05	CcSEcCtD
Etoposide—Fatigue—Prednisone—hematologic cancer	2.47e-06	6.04e-05	CcSEcCtD
Etoposide—Headache—Prednisolone—hematologic cancer	2.47e-06	6.04e-05	CcSEcCtD
Etoposide—Discomfort—Methotrexate—hematologic cancer	2.47e-06	6.03e-05	CcSEcCtD
Etoposide—Vertigo—Epirubicin—hematologic cancer	2.47e-06	6.03e-05	CcSEcCtD
Etoposide—Leukopenia—Epirubicin—hematologic cancer	2.46e-06	6.01e-05	CcSEcCtD
Etoposide—Back pain—Doxorubicin—hematologic cancer	2.46e-06	6.01e-05	CcSEcCtD
Etoposide—Constipation—Prednisone—hematologic cancer	2.45e-06	5.99e-05	CcSEcCtD
Etoposide—Muscle spasms—Doxorubicin—hematologic cancer	2.45e-06	5.97e-05	CcSEcCtD
Etoposide—Confusional state—Methotrexate—hematologic cancer	2.42e-06	5.9e-05	CcSEcCtD
Etoposide—Loss of consciousness—Epirubicin—hematologic cancer	2.42e-06	5.9e-05	CcSEcCtD
Etoposide—Dizziness—Triamcinolone—hematologic cancer	2.4e-06	5.86e-05	CcSEcCtD
Etoposide—Cough—Epirubicin—hematologic cancer	2.4e-06	5.86e-05	CcSEcCtD
Etoposide—Anaphylactic shock—Methotrexate—hematologic cancer	2.4e-06	5.85e-05	CcSEcCtD
Etoposide—Convulsion—Epirubicin—hematologic cancer	2.38e-06	5.82e-05	CcSEcCtD
Etoposide—Infection—Methotrexate—hematologic cancer	2.38e-06	5.82e-05	CcSEcCtD
Etoposide—Hypertension—Epirubicin—hematologic cancer	2.37e-06	5.8e-05	CcSEcCtD
Etoposide—Feeling abnormal—Prednisone—hematologic cancer	2.36e-06	5.77e-05	CcSEcCtD
Etoposide—Asthenia—Betamethasone—hematologic cancer	2.36e-06	5.77e-05	CcSEcCtD
Etoposide—Asthenia—Dexamethasone—hematologic cancer	2.36e-06	5.77e-05	CcSEcCtD
Etoposide—Ill-defined disorder—Doxorubicin—hematologic cancer	2.36e-06	5.76e-05	CcSEcCtD
Etoposide—Anaemia—Doxorubicin—hematologic cancer	2.35e-06	5.74e-05	CcSEcCtD
Etoposide—Thrombocytopenia—Methotrexate—hematologic cancer	2.35e-06	5.73e-05	CcSEcCtD
Etoposide—Gastrointestinal pain—Prednisone—hematologic cancer	2.35e-06	5.73e-05	CcSEcCtD
Etoposide—Nausea—Prednisolone—hematologic cancer	2.35e-06	5.73e-05	CcSEcCtD
Etoposide—Chest pain—Epirubicin—hematologic cancer	2.34e-06	5.72e-05	CcSEcCtD
Etoposide—Pruritus—Dexamethasone—hematologic cancer	2.33e-06	5.69e-05	CcSEcCtD
Etoposide—Pruritus—Betamethasone—hematologic cancer	2.33e-06	5.69e-05	CcSEcCtD
Etoposide—Skin disorder—Methotrexate—hematologic cancer	2.33e-06	5.69e-05	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.32e-06	5.68e-05	CcSEcCtD
Etoposide—Hyperhidrosis—Methotrexate—hematologic cancer	2.32e-06	5.66e-05	CcSEcCtD
Etoposide—Discomfort—Epirubicin—hematologic cancer	2.31e-06	5.65e-05	CcSEcCtD
Etoposide—Vomiting—Triamcinolone—hematologic cancer	2.31e-06	5.64e-05	CcSEcCtD
Etoposide—Malaise—Doxorubicin—hematologic cancer	2.29e-06	5.6e-05	CcSEcCtD
Etoposide—Rash—Triamcinolone—hematologic cancer	2.29e-06	5.59e-05	CcSEcCtD
Etoposide—Dermatitis—Triamcinolone—hematologic cancer	2.29e-06	5.58e-05	CcSEcCtD
Etoposide—Vertigo—Doxorubicin—hematologic cancer	2.29e-06	5.58e-05	CcSEcCtD
Etoposide—Anorexia—Methotrexate—hematologic cancer	2.29e-06	5.58e-05	CcSEcCtD
Etoposide—Urticaria—Prednisone—hematologic cancer	2.28e-06	5.57e-05	CcSEcCtD
Etoposide—Leukopenia—Doxorubicin—hematologic cancer	2.28e-06	5.56e-05	CcSEcCtD
Etoposide—Headache—Triamcinolone—hematologic cancer	2.27e-06	5.55e-05	CcSEcCtD
Etoposide—Body temperature increased—Prednisone—hematologic cancer	2.27e-06	5.54e-05	CcSEcCtD
Etoposide—Abdominal pain—Prednisone—hematologic cancer	2.27e-06	5.54e-05	CcSEcCtD
Etoposide—Confusional state—Epirubicin—hematologic cancer	2.26e-06	5.52e-05	CcSEcCtD
Etoposide—Diarrhoea—Betamethasone—hematologic cancer	2.25e-06	5.5e-05	CcSEcCtD
Etoposide—Diarrhoea—Dexamethasone—hematologic cancer	2.25e-06	5.5e-05	CcSEcCtD
Etoposide—Anaphylactic shock—Epirubicin—hematologic cancer	2.24e-06	5.48e-05	CcSEcCtD
Etoposide—Hypotension—Methotrexate—hematologic cancer	2.24e-06	5.47e-05	CcSEcCtD
Etoposide—Loss of consciousness—Doxorubicin—hematologic cancer	2.24e-06	5.46e-05	CcSEcCtD
Etoposide—Infection—Epirubicin—hematologic cancer	2.23e-06	5.44e-05	CcSEcCtD
Etoposide—Cough—Doxorubicin—hematologic cancer	2.22e-06	5.42e-05	CcSEcCtD
Etoposide—Convulsion—Doxorubicin—hematologic cancer	2.2e-06	5.38e-05	CcSEcCtD
Etoposide—Thrombocytopenia—Epirubicin—hematologic cancer	2.2e-06	5.36e-05	CcSEcCtD
Etoposide—Hypertension—Doxorubicin—hematologic cancer	2.2e-06	5.36e-05	CcSEcCtD
Etoposide—Tachycardia—Epirubicin—hematologic cancer	2.19e-06	5.35e-05	CcSEcCtD
Etoposide—Skin disorder—Epirubicin—hematologic cancer	2.18e-06	5.32e-05	CcSEcCtD
Etoposide—Dizziness—Dexamethasone—hematologic cancer	2.18e-06	5.32e-05	CcSEcCtD
Etoposide—Dizziness—Betamethasone—hematologic cancer	2.18e-06	5.32e-05	CcSEcCtD
Etoposide—Hyperhidrosis—Epirubicin—hematologic cancer	2.17e-06	5.3e-05	CcSEcCtD
Etoposide—Chest pain—Doxorubicin—hematologic cancer	2.17e-06	5.29e-05	CcSEcCtD
Etoposide—Nausea—Triamcinolone—hematologic cancer	2.16e-06	5.27e-05	CcSEcCtD
Etoposide—Paraesthesia—Methotrexate—hematologic cancer	2.15e-06	5.26e-05	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.15e-06	5.25e-05	CcSEcCtD
Etoposide—Discomfort—Doxorubicin—hematologic cancer	2.14e-06	5.23e-05	CcSEcCtD
Etoposide—Anorexia—Epirubicin—hematologic cancer	2.14e-06	5.22e-05	CcSEcCtD
Etoposide—Dyspnoea—Methotrexate—hematologic cancer	2.14e-06	5.22e-05	CcSEcCtD
Etoposide—Somnolence—Methotrexate—hematologic cancer	2.13e-06	5.2e-05	CcSEcCtD
Etoposide—Hypersensitivity—Prednisone—hematologic cancer	2.11e-06	5.16e-05	CcSEcCtD
Etoposide—Hypotension—Epirubicin—hematologic cancer	2.1e-06	5.12e-05	CcSEcCtD
Etoposide—Vomiting—Dexamethasone—hematologic cancer	2.09e-06	5.11e-05	CcSEcCtD
Etoposide—Vomiting—Betamethasone—hematologic cancer	2.09e-06	5.11e-05	CcSEcCtD
Etoposide—Confusional state—Doxorubicin—hematologic cancer	2.09e-06	5.11e-05	CcSEcCtD
Etoposide—Decreased appetite—Methotrexate—hematologic cancer	2.08e-06	5.09e-05	CcSEcCtD
Etoposide—Rash—Dexamethasone—hematologic cancer	2.08e-06	5.07e-05	CcSEcCtD
Etoposide—Rash—Betamethasone—hematologic cancer	2.08e-06	5.07e-05	CcSEcCtD
Etoposide—Anaphylactic shock—Doxorubicin—hematologic cancer	2.08e-06	5.07e-05	CcSEcCtD
Etoposide—Dermatitis—Betamethasone—hematologic cancer	2.08e-06	5.07e-05	CcSEcCtD
Etoposide—Dermatitis—Dexamethasone—hematologic cancer	2.08e-06	5.07e-05	CcSEcCtD
Etoposide—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.07e-06	5.05e-05	CcSEcCtD
Etoposide—Fatigue—Methotrexate—hematologic cancer	2.07e-06	5.05e-05	CcSEcCtD
Etoposide—Headache—Dexamethasone—hematologic cancer	2.06e-06	5.04e-05	CcSEcCtD
Etoposide—Headache—Betamethasone—hematologic cancer	2.06e-06	5.04e-05	CcSEcCtD
Etoposide—Infection—Doxorubicin—hematologic cancer	2.06e-06	5.04e-05	CcSEcCtD
Etoposide—Asthenia—Prednisone—hematologic cancer	2.06e-06	5.03e-05	CcSEcCtD
Etoposide—Pain—Methotrexate—hematologic cancer	2.05e-06	5.01e-05	CcSEcCtD
Etoposide—Thrombocytopenia—Doxorubicin—hematologic cancer	2.03e-06	4.96e-05	CcSEcCtD
Etoposide—Pruritus—Prednisone—hematologic cancer	2.03e-06	4.96e-05	CcSEcCtD
Etoposide—Tachycardia—Doxorubicin—hematologic cancer	2.03e-06	4.95e-05	CcSEcCtD
Etoposide—Skin disorder—Doxorubicin—hematologic cancer	2.02e-06	4.92e-05	CcSEcCtD
Etoposide—Paraesthesia—Epirubicin—hematologic cancer	2.02e-06	4.92e-05	CcSEcCtD
Etoposide—Hyperhidrosis—Doxorubicin—hematologic cancer	2.01e-06	4.9e-05	CcSEcCtD
Etoposide—Dyspnoea—Epirubicin—hematologic cancer	2e-06	4.88e-05	CcSEcCtD
Etoposide—Somnolence—Epirubicin—hematologic cancer	2e-06	4.87e-05	CcSEcCtD
Etoposide—Anorexia—Doxorubicin—hematologic cancer	1.98e-06	4.83e-05	CcSEcCtD
Etoposide—Feeling abnormal—Methotrexate—hematologic cancer	1.98e-06	4.82e-05	CcSEcCtD
Etoposide—Diarrhoea—Prednisone—hematologic cancer	1.96e-06	4.79e-05	CcSEcCtD
Etoposide—Gastrointestinal pain—Methotrexate—hematologic cancer	1.96e-06	4.79e-05	CcSEcCtD
Etoposide—Nausea—Betamethasone—hematologic cancer	1.96e-06	4.78e-05	CcSEcCtD
Etoposide—Nausea—Dexamethasone—hematologic cancer	1.96e-06	4.78e-05	CcSEcCtD
Etoposide—Decreased appetite—Epirubicin—hematologic cancer	1.95e-06	4.76e-05	CcSEcCtD
Etoposide—Hypotension—Doxorubicin—hematologic cancer	1.94e-06	4.74e-05	CcSEcCtD
Etoposide—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.94e-06	4.73e-05	CcSEcCtD
Etoposide—Fatigue—Epirubicin—hematologic cancer	1.93e-06	4.72e-05	CcSEcCtD
Etoposide—Pain—Epirubicin—hematologic cancer	1.92e-06	4.69e-05	CcSEcCtD
Etoposide—Constipation—Epirubicin—hematologic cancer	1.92e-06	4.69e-05	CcSEcCtD
Etoposide—Urticaria—Methotrexate—hematologic cancer	1.91e-06	4.65e-05	CcSEcCtD
Etoposide—Dizziness—Prednisone—hematologic cancer	1.9e-06	4.63e-05	CcSEcCtD
Etoposide—Body temperature increased—Methotrexate—hematologic cancer	1.9e-06	4.63e-05	CcSEcCtD
Etoposide—Abdominal pain—Methotrexate—hematologic cancer	1.9e-06	4.63e-05	CcSEcCtD
Etoposide—Paraesthesia—Doxorubicin—hematologic cancer	1.86e-06	4.55e-05	CcSEcCtD
Etoposide—Dyspnoea—Doxorubicin—hematologic cancer	1.85e-06	4.52e-05	CcSEcCtD
Etoposide—Feeling abnormal—Epirubicin—hematologic cancer	1.85e-06	4.52e-05	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	1.85e-06	0.0029	CbGdCrCtD
Etoposide—Somnolence—Doxorubicin—hematologic cancer	1.85e-06	4.51e-05	CcSEcCtD
Etoposide—Gastrointestinal pain—Epirubicin—hematologic cancer	1.84e-06	4.48e-05	CcSEcCtD
Etoposide—Vomiting—Prednisone—hematologic cancer	1.82e-06	4.45e-05	CcSEcCtD
Etoposide—Rash—Prednisone—hematologic cancer	1.81e-06	4.42e-05	CcSEcCtD
Etoposide—Dermatitis—Prednisone—hematologic cancer	1.81e-06	4.41e-05	CcSEcCtD
Etoposide—Decreased appetite—Doxorubicin—hematologic cancer	1.81e-06	4.41e-05	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	1.8e-06	0.00283	CbGdCrCtD
Etoposide—Headache—Prednisone—hematologic cancer	1.8e-06	4.39e-05	CcSEcCtD
Etoposide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.79e-06	4.38e-05	CcSEcCtD
Etoposide—Fatigue—Doxorubicin—hematologic cancer	1.79e-06	4.37e-05	CcSEcCtD
Etoposide—Urticaria—Epirubicin—hematologic cancer	1.78e-06	4.35e-05	CcSEcCtD
Etoposide—Pain—Doxorubicin—hematologic cancer	1.78e-06	4.34e-05	CcSEcCtD
Etoposide—Constipation—Doxorubicin—hematologic cancer	1.78e-06	4.34e-05	CcSEcCtD
Etoposide—Abdominal pain—Epirubicin—hematologic cancer	1.77e-06	4.33e-05	CcSEcCtD
Etoposide—Body temperature increased—Epirubicin—hematologic cancer	1.77e-06	4.33e-05	CcSEcCtD
Etoposide—Hypersensitivity—Methotrexate—hematologic cancer	1.77e-06	4.31e-05	CcSEcCtD
Etoposide—Asthenia—Methotrexate—hematologic cancer	1.72e-06	4.2e-05	CcSEcCtD
Etoposide—Feeling abnormal—Doxorubicin—hematologic cancer	1.71e-06	4.18e-05	CcSEcCtD
Etoposide—Nausea—Prednisone—hematologic cancer	1.7e-06	4.16e-05	CcSEcCtD
Etoposide—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.7e-06	4.15e-05	CcSEcCtD
Etoposide—Pruritus—Methotrexate—hematologic cancer	1.7e-06	4.14e-05	CcSEcCtD
Etoposide—Hypersensitivity—Epirubicin—hematologic cancer	1.65e-06	4.04e-05	CcSEcCtD
Etoposide—Urticaria—Doxorubicin—hematologic cancer	1.65e-06	4.03e-05	CcSEcCtD
Etoposide—Abdominal pain—Doxorubicin—hematologic cancer	1.64e-06	4.01e-05	CcSEcCtD
Etoposide—Body temperature increased—Doxorubicin—hematologic cancer	1.64e-06	4.01e-05	CcSEcCtD
Etoposide—Diarrhoea—Methotrexate—hematologic cancer	1.64e-06	4.01e-05	CcSEcCtD
Etoposide—Asthenia—Epirubicin—hematologic cancer	1.61e-06	3.93e-05	CcSEcCtD
Etoposide—Pruritus—Epirubicin—hematologic cancer	1.59e-06	3.88e-05	CcSEcCtD
Etoposide—Dizziness—Methotrexate—hematologic cancer	1.59e-06	3.87e-05	CcSEcCtD
Etoposide—Diarrhoea—Epirubicin—hematologic cancer	1.54e-06	3.75e-05	CcSEcCtD
Etoposide—Hypersensitivity—Doxorubicin—hematologic cancer	1.53e-06	3.74e-05	CcSEcCtD
Etoposide—Vomiting—Methotrexate—hematologic cancer	1.52e-06	3.72e-05	CcSEcCtD
Etoposide—Rash—Methotrexate—hematologic cancer	1.51e-06	3.69e-05	CcSEcCtD
Etoposide—Dermatitis—Methotrexate—hematologic cancer	1.51e-06	3.69e-05	CcSEcCtD
Etoposide—Headache—Methotrexate—hematologic cancer	1.5e-06	3.67e-05	CcSEcCtD
Etoposide—Asthenia—Doxorubicin—hematologic cancer	1.49e-06	3.64e-05	CcSEcCtD
Etoposide—Dizziness—Epirubicin—hematologic cancer	1.48e-06	3.62e-05	CcSEcCtD
Etoposide—Pruritus—Doxorubicin—hematologic cancer	1.47e-06	3.59e-05	CcSEcCtD
Etoposide—Vomiting—Epirubicin—hematologic cancer	1.43e-06	3.48e-05	CcSEcCtD
Etoposide—Nausea—Methotrexate—hematologic cancer	1.42e-06	3.48e-05	CcSEcCtD
Etoposide—Diarrhoea—Doxorubicin—hematologic cancer	1.42e-06	3.47e-05	CcSEcCtD
Etoposide—Rash—Epirubicin—hematologic cancer	1.42e-06	3.45e-05	CcSEcCtD
Etoposide—Dermatitis—Epirubicin—hematologic cancer	1.41e-06	3.45e-05	CcSEcCtD
Etoposide—Headache—Epirubicin—hematologic cancer	1.41e-06	3.43e-05	CcSEcCtD
Etoposide—Dizziness—Doxorubicin—hematologic cancer	1.37e-06	3.35e-05	CcSEcCtD
Etoposide—Nausea—Epirubicin—hematologic cancer	1.33e-06	3.25e-05	CcSEcCtD
Etoposide—Vomiting—Doxorubicin—hematologic cancer	1.32e-06	3.22e-05	CcSEcCtD
Etoposide—Rash—Doxorubicin—hematologic cancer	1.31e-06	3.2e-05	CcSEcCtD
Etoposide—Dermatitis—Doxorubicin—hematologic cancer	1.31e-06	3.19e-05	CcSEcCtD
Etoposide—Headache—Doxorubicin—hematologic cancer	1.3e-06	3.18e-05	CcSEcCtD
Etoposide—Nausea—Doxorubicin—hematologic cancer	1.23e-06	3.01e-05	CcSEcCtD
Etoposide—CYP2C8—Metabolism—CYCS—hematologic cancer	4.84e-07	3.06e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—TSC2—hematologic cancer	4.84e-07	3.06e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—NCOR1—hematologic cancer	4.82e-07	3.04e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTM1—hematologic cancer	4.82e-07	3.04e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	4.81e-07	3.04e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ALB—hematologic cancer	4.8e-07	3.03e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NUP98—hematologic cancer	4.77e-07	3.01e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.73e-07	2.99e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.71e-07	2.98e-05	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.7e-07	2.97e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CG—hematologic cancer	4.69e-07	2.96e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CD—hematologic cancer	4.69e-07	2.96e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ABCB1—hematologic cancer	4.67e-07	2.95e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.67e-07	2.95e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—FGFR3—hematologic cancer	4.66e-07	2.94e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.63e-07	2.92e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.63e-07	2.92e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ALB—hematologic cancer	4.63e-07	2.92e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NUP214—hematologic cancer	4.6e-07	2.9e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3R1—hematologic cancer	4.59e-07	2.9e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CA9—hematologic cancer	4.59e-07	2.89e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ACP5—hematologic cancer	4.59e-07	2.89e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1B—hematologic cancer	4.58e-07	2.89e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.55e-07	2.87e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTM1—hematologic cancer	4.54e-07	2.87e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—NCOR1—hematologic cancer	4.54e-07	2.87e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTM1—hematologic cancer	4.53e-07	2.86e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—NCOR1—hematologic cancer	4.53e-07	2.86e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.53e-07	2.86e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CG—hematologic cancer	4.51e-07	2.85e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTEN—hematologic cancer	4.51e-07	2.85e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.5e-07	2.84e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—MTR—hematologic cancer	4.5e-07	2.84e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CD44—hematologic cancer	4.46e-07	2.81e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NQO1—hematologic cancer	4.46e-07	2.81e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3R1—hematologic cancer	4.43e-07	2.8e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ENO2—hematologic cancer	4.42e-07	2.79e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—BAD—hematologic cancer	4.41e-07	2.79e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOTCH1—hematologic cancer	4.37e-07	2.76e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CREBBP—hematologic cancer	4.35e-07	2.75e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.33e-07	2.73e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—IDH1—hematologic cancer	4.31e-07	2.72e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—EP300—hematologic cancer	4.3e-07	2.71e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.28e-07	2.7e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CD80—hematologic cancer	4.28e-07	2.7e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—KIT—hematologic cancer	4.27e-07	2.7e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.27e-07	2.69e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TXN—hematologic cancer	4.26e-07	2.69e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.26e-07	2.69e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.26e-07	2.69e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—MTHFR—hematologic cancer	4.26e-07	2.69e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CB—hematologic cancer	4.24e-07	2.68e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1A—hematologic cancer	4.23e-07	2.67e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYCS—hematologic cancer	4.22e-07	2.66e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.22e-07	2.66e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTEN—hematologic cancer	4.22e-07	2.66e-05	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—hematologic cancer	4.2e-07	2.65e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PTPN11—hematologic cancer	4.2e-07	2.65e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.19e-07	2.65e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SDC1—hematologic cancer	4.19e-07	2.64e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CREBBP—hematologic cancer	4.18e-07	2.64e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.17e-07	2.63e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.13e-07	2.61e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CD—hematologic cancer	4.13e-07	2.6e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CB—hematologic cancer	4.09e-07	2.58e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ALB—hematologic cancer	4.07e-07	2.57e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CREB1—hematologic cancer	4.07e-07	2.57e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.04e-07	2.55e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—EP300—hematologic cancer	4.02e-07	2.54e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—BRAF—hematologic cancer	4.02e-07	2.54e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—MTHFR—hematologic cancer	4.01e-07	2.53e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.01e-07	2.53e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—MTHFR—hematologic cancer	4e-07	2.53e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4e-07	2.52e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6R—hematologic cancer	3.97e-07	2.51e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CD—hematologic cancer	3.96e-07	2.5e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CREBBP—hematologic cancer	3.96e-07	2.5e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.95e-07	2.49e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.92e-07	2.48e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.92e-07	2.48e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ALB—hematologic cancer	3.91e-07	2.47e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—SRC—hematologic cancer	3.91e-07	2.47e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.9e-07	2.46e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.9e-07	2.46e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3R1—hematologic cancer	3.9e-07	2.46e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.8e-07	2.4e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAP2K1—hematologic cancer	3.78e-07	2.39e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.78e-07	2.38e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—STAT3—hematologic cancer	3.77e-07	2.38e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—NRAS—hematologic cancer	3.76e-07	2.38e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CD—hematologic cancer	3.76e-07	2.37e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.75e-07	2.37e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3R1—hematologic cancer	3.74e-07	2.36e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTP1—hematologic cancer	3.72e-07	2.35e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NUP98—hematologic cancer	3.68e-07	2.32e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTEN—hematologic cancer	3.66e-07	2.31e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAPK3—hematologic cancer	3.6e-07	2.27e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—FGF2—hematologic cancer	3.6e-07	2.27e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CB—hematologic cancer	3.6e-07	2.27e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CG—hematologic cancer	3.58e-07	2.26e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.57e-07	2.26e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.57e-07	2.26e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CD44—hematologic cancer	3.56e-07	2.25e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NQO1—hematologic cancer	3.56e-07	2.25e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3R1—hematologic cancer	3.55e-07	2.24e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NUP214—hematologic cancer	3.55e-07	2.24e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTEN—hematologic cancer	3.53e-07	2.23e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—hematologic cancer	3.5e-07	2.21e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—TGFB1—hematologic cancer	3.5e-07	2.21e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—EP300—hematologic cancer	3.49e-07	2.21e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.49e-07	2.2e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—MTR—hematologic cancer	3.48e-07	2.19e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.48e-07	2.19e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.47e-07	2.19e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CB—hematologic cancer	3.46e-07	2.18e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—JAK2—hematologic cancer	3.45e-07	2.18e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NCOR1—hematologic cancer	3.42e-07	2.16e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTM1—hematologic cancer	3.42e-07	2.16e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ENO2—hematologic cancer	3.41e-07	2.15e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CG—hematologic cancer	3.37e-07	2.13e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—EP300—hematologic cancer	3.37e-07	2.13e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYCS—hematologic cancer	3.37e-07	2.13e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MDM2—hematologic cancer	3.37e-07	2.13e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.36e-07	2.12e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.35e-07	2.11e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CREBBP—hematologic cancer	3.32e-07	2.1e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.31e-07	2.09e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CB—hematologic cancer	3.28e-07	2.07e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MTOR—hematologic cancer	3.28e-07	2.07e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CD4—hematologic cancer	3.27e-07	2.06e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—KRAS—hematologic cancer	3.24e-07	2.04e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SDC1—hematologic cancer	3.23e-07	2.04e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CA—hematologic cancer	3.18e-07	2.01e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CD—hematologic cancer	3.15e-07	1.99e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CREBBP—hematologic cancer	3.12e-07	1.97e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CREBBP—hematologic cancer	3.12e-07	1.97e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTEN—hematologic cancer	3.11e-07	1.96e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ALB—hematologic cancer	3.11e-07	1.96e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1B—hematologic cancer	3.07e-07	1.94e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.06e-07	1.93e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—MTHFR—hematologic cancer	3.02e-07	1.91e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.01e-07	1.9e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTEN—hematologic cancer	2.99e-07	1.88e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CA—hematologic cancer	2.98e-07	1.88e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3R1—hematologic cancer	2.97e-07	1.88e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.97e-07	1.87e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—EP300—hematologic cancer	2.96e-07	1.87e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.96e-07	1.87e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.96e-07	1.87e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ALB—hematologic cancer	2.92e-07	1.85e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ALB—hematologic cancer	2.92e-07	1.84e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.91e-07	1.84e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.87e-07	1.81e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—EP300—hematologic cancer	2.85e-07	1.8e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1A—hematologic cancer	2.84e-07	1.79e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PTEN—hematologic cancer	2.83e-07	1.79e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.81e-07	1.77e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.8e-07	1.77e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.79e-07	1.76e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—HRAS—hematologic cancer	2.75e-07	1.74e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CD44—hematologic cancer	2.75e-07	1.73e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NQO1—hematologic cancer	2.75e-07	1.73e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CB—hematologic cancer	2.74e-07	1.73e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.73e-07	1.72e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.73e-07	1.72e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.7e-07	1.7e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EP300—hematologic cancer	2.7e-07	1.7e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—IL6—hematologic cancer	2.63e-07	1.66e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—SRC—hematologic cancer	2.62e-07	1.66e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYCS—hematologic cancer	2.6e-07	1.64e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—hematologic cancer	2.6e-07	1.64e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CA—hematologic cancer	2.58e-07	1.63e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.58e-07	1.63e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.58e-07	1.63e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.58e-07	1.63e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.56e-07	1.62e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.54e-07	1.6e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—STAT3—hematologic cancer	2.53e-07	1.6e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ALB—hematologic cancer	2.53e-07	1.6e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NRAS—hematologic cancer	2.53e-07	1.59e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CA—hematologic cancer	2.49e-07	1.57e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—hematologic cancer	2.43e-07	1.53e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAPK3—hematologic cancer	2.42e-07	1.53e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.42e-07	1.53e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.41e-07	1.52e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PTEN—hematologic cancer	2.37e-07	1.5e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CREBBP—hematologic cancer	2.35e-07	1.49e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—hematologic cancer	2.35e-07	1.48e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—TGFB1—hematologic cancer	2.35e-07	1.48e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.29e-07	1.45e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—EP300—hematologic cancer	2.26e-07	1.43e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.23e-07	1.41e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTEN—hematologic cancer	2.23e-07	1.41e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.23e-07	1.41e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTEN—hematologic cancer	2.23e-07	1.41e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ALB—hematologic cancer	2.2e-07	1.39e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CA—hematologic cancer	2.19e-07	1.38e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—KRAS—hematologic cancer	2.17e-07	1.37e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.17e-07	1.37e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—EP300—hematologic cancer	2.13e-07	1.34e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.12e-07	1.34e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—EP300—hematologic cancer	2.12e-07	1.34e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—hematologic cancer	2.11e-07	1.33e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.11e-07	1.33e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CA—hematologic cancer	2.11e-07	1.33e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.11e-07	1.33e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.11e-07	1.33e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—hematologic cancer	2.04e-07	1.28e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.03e-07	1.28e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CA—hematologic cancer	2e-07	1.26e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.94e-07	1.23e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTEN—hematologic cancer	1.93e-07	1.22e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.88e-07	1.19e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.86e-07	1.17e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HRAS—hematologic cancer	1.85e-07	1.17e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—EP300—hematologic cancer	1.84e-07	1.16e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—hematologic cancer	1.79e-07	1.13e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.78e-07	1.12e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6—hematologic cancer	1.77e-07	1.12e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALB—hematologic cancer	1.76e-07	1.11e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—hematologic cancer	1.72e-07	1.09e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.68e-07	1.06e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTEN—hematologic cancer	1.68e-07	1.06e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CA—hematologic cancer	1.67e-07	1.06e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—hematologic cancer	1.63e-07	1.03e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—EP300—hematologic cancer	1.6e-07	1.01e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.57e-07	9.94e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.57e-07	9.92e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.56e-07	9.87e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.55e-07	9.8e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.45e-07	9.15e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.37e-07	8.68e-06	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—hematologic cancer	1.37e-07	8.62e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.36e-07	8.59e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALB—hematologic cancer	1.36e-07	8.57e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTEN—hematologic cancer	1.34e-07	8.47e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.3e-07	8.19e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—hematologic cancer	1.29e-07	8.12e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—hematologic cancer	1.28e-07	8.1e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—EP300—hematologic cancer	1.28e-07	8.08e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.2e-07	7.56e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.19e-07	7.48e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—hematologic cancer	1.11e-07	7.02e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTEN—hematologic cancer	1.04e-07	6.54e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—EP300—hematologic cancer	9.87e-08	6.23e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—hematologic cancer	9.68e-08	6.11e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CA—hematologic cancer	9.46e-08	5.97e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—hematologic cancer	7.73e-08	4.88e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.3e-08	4.61e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—hematologic cancer	5.97e-08	3.77e-06	CbGpPWpGaD
